A meta-analysis of randomised controlled trials assessing drug-eluting stents and vascular brachytherapy in the treatment of coronary artery in-stent restenosis

International Journal of Cardiology

Volumn 126, Issue 2, 2008, Pages 216-223

  Oliver, Lisa N ^a   Buttner, Petra G ^a   Hobson, Helen ^a   Golledge, Jonathan ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

Drug eluting stent; In stent restenosis; Vascular brachytherapy

Indexed keywords

ARTICLE; ATHERECTOMY; BRACHYTHERAPY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; MEDICAL ASSESSMENT; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; SYSTEMATIC REVIEW;

AGED; BRACHYTHERAPY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 42949152866     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.03.132     Document Type: Article

References (42)

1. Dawkins K.D., Gershlick T., de Belder M., et al. Percutaneous coronary intervention: recommendations for good practice and training. Heart 91 Suppl 6 (2005) vi1-vi27
2. Babapulle M.N., Joseph L., Belisle P., Brophy J.M., and Eisenberg M.J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364 (2004) 583-591
3. Lemos P.A., Arampatzis C.A., Saia F., et al. Treatment of very small vessels with 2.25 mm diameter sirolimus-eluting stents. Am J Cardiol 93 (2004) 633-636
4. Moussa I., Leon M.B., Baim D.S., et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolimUS-coated Bx Velocity balloon expendable stent in the treatment of patients with de-novo coronary artery lesions) substudy. Circulation 109 (2004) 2273-2278
5. Albiero R., Silber S., Di Mario C., et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol 43 (2004) 943-949
6. Albiero R., Silber S., Di Mario C., et al. RESCUT Investigators. Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study. J Am Coll Cardiol 46 (2005) 756-760
7. vom Dahl J., Dietz U., Haager P.K., et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 105 (2002) 583-588
8. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. Eur Heart J 26 (2005) 804-847
9. Thomas M.R. Brachytherapy: here today, gone tomorrow?. Heart 91 Suppl III (2005) iii32-iii34
10. Kaluza G.L., and Raizner A.E. Brachytherapy for restenosis after stenting for coronary artery disease: its role in the drug-eluting era. Curr Opin Cardiol 19 (2004) 601-607
11. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354 (1999) 1896-1900
12. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
13. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
14. Lin L.I.-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45 (1989) 255-268
15. Teirstein P.S., Massullo V., Jani S., et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 336 (1997) 1697-1703
16. Teirstein P.S., Massullo V., Jani S., et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomised clinical trial. Circulation 101 (2000) 360-365
17. Grise M.A., Massullo V., Jani S., et al. Five-year clinical follow-up after intracoronary radiation: results of a randomised clinical trial. Circulation 105 (2002) 2737-2740
18. Raizner A.E., Oesterle S.N., Waksman R., et al. Inhibition of restenosis with β-emitting radiotherapy: report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 102 (2000) 951-958
19. Waksman R., White R.L., Chan R.C., et al. Intracoronary γ-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 101 (2000) 2165-2171
20. Ajani A.E., Waksman R., Sharma A.K., et al. Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis: original WRIST. Cardiovasc Radiat Med 2 (2001) 200-204
21. Waksman R., Ajani A.E., White R.L., et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 109 (2004) 340-344
22. Leon M.B., Teirstein P.S., Moses J.W., et al. Localised intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 344 (2001) 250-256
23. 188Re liquid-filled balloon. Am J Cardiol 87 (2001) 463-466
24. Waksman R., Raizner A.E., Yeung A.C., Lansky A.J., and Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 359 (2002) 551-557
25. 90Y β-radiation versus placebo control for the treatment of in-stent restenosis. Circulation 166 (2002) 1090-1096
26. 90Y β-radiation versus placebo control for the treatment of in-stent restenosis. Am Heart J 149 (2005) 689-694
27. Waksman R., Ajani A.E., White R.L., et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 346 (2002) 1194-1199
28. Rha S.W., Kuchulakanti P., Ajani A.E., et al. Three-year follow-up after intravascular γ-radiation for in-stent restenosis in saphenous vein grafts. Catheter Cardiovasc Interv 65 (2005) 257-262
29. Hoher M., Wohrle J., Wohlfrom M., et al. Intracoronary β-irradiation with a rhenium-188-filled balloon catheter: a randomised trial in patients with de novo and restenotic lesions. Circulation 107 (2003) 3022-3027
30. Waksman R., Cheneau E., Ajani A.E., et al. Washington radiation for in-stent restenosis trial for long lesions studies. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long lesions (Long-WRIST) studies. Circulation 107 (2003) 1744-1749
31. Cheneau E., Canos D., Pinnow E., et al. Impact of radiation dose on late clinical outcome after intracoronary radiation therapy: three-year follow-up of long-WRIST. Catheter Cardiovasc Interv 62 (2004) 318-322
32. Kim K.I., Bae J., Kang H.J., et al. Three-year clinical follow-up results of intracoronary radiation therapy using a rhenium-188-diethylene-triamine-penta-acetic-acid-filled balloon system. Circ J 68 (2004) 532-537
33. Kastrati A., Mehilli J., von Beckerath N., et al. Sirolimus-eluting stent or paclitaxel-eluting stent versus balloon angioplasty for prevention of recurrences inpatients with coronary artery in-stent restenosis: a randomised controlled trial. JAMA 293 (2005) 165-171
34. Holmes Jr. D.R., Teirstein P., Satler L., et al. Sirolimus-eluting stents versus vascular brachytherapy for in-stent restenosis within bare-metal stents. JAMA 295 (2006) 1264-1273
35. Stone G.W., Ellis S.G., O'Shaughnessy C.D., et al. Paclitaxel-eluting stents versus vascular brachytherapy within bare-metal stents; the TAXUS V ISR randomised trial. JAMA 295 (2006) 1253-1263
36. Durairaj A., and Faxon D.P. The ARTISTIC and ARREST trials. J Invasive Cardiol 12 (2000) 44-49
37. Stone G.W., Mehran R., Midei M., et al. Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. Am J Cardiol 92 (2003) 312-314
38. Mauri L., Orav E.J., Candia S.C., Cutlip D.E., and Kuntz R.E. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation 112 (2005) 2833-2839
39. Brophy J.M., Belisle P., and Joseph L. Evidence for use of coronary stents. A hierarchical Bayesian meta-analysis. Ann Intern Med 138 (2003) 777-786
40. Nordmann A.J., Briel M., and Bucher H.C. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27 (2006) 2784-2814
41. Dibra A., Kastrati A., Alfonso F., et al. Effectiveness of drug eluting stents in patients with bare-metal in-stent restenosis: meta analysis of randomized trials. J Am Coll Cardiol 49 (2007) 616-623
42. Maisel W.H. Unanswered questions - drug-eluting stents and the risk of late thrombosis. N Engl J Med 356 (2007) 981-984